Rosa DeLauro
Rosa DeLauro is ready for your opinion, support and vote. Vote online NOW!
|
Democratic |
|||||||
 |
Rosa DeLauro - forThe U.S. Representative for Connecticut's 3rd congressional district, serving since 1991.
|
 |
Rosa DeLauro - againstClick, if you do not support Rosa DeLauro . Say why.
|
||||
|
||||||
 
|
||||||||
Biography
|
|
||||||||||||||
> Rosa DeLauro > Online statistics and voting results |
|||||||||||||||
|
|||||||||||||||
|
|
Representative Rosa DeLauro Visits Hampford Research, Inc.
Congresswoman Rosa DeLauro (D-CT) this week visited SOCMA member Hampford Research, Inc.'s (HRI) chemical manufacturing facility in Stratford, CT. During an initial meeting with company leadership, HRI staff asked DeLauro to support a long-term extension of Chemical Facility Anti-Terrorism Standards (CFATS) legislation, improve the process by which the Miscellaneous Tariff Bill (MTB) is passed, and modernize the Toxic Substances Control Act (TSCA). Following the meeting, HRI staff gave a tour of their manufacturing facility, which specializes in photochemical and radiation-cured monomers ...
DeLauro: Still Hangin’ With the Connecticut Communists
I have written previously of Rep.Rosa DeLauros’sclose ties tothe Connecticut Communist Party. Rosa DeLauro is one of Congress’ highest ranking Democrats. She is particularly close to another long time friend of communist causes, former Speaker of the HouseNancy Pelosi. It appears that , while one the Democratic Party’s most influential legislators, Rep. DeLauro still thinks it is appropriate to work closely with Marxist-Leninists. Rep. DeLauro is very close toConnecticut Communist PartyleaderJoelle Fishman, the daughter-in-law of late Soviet spy andCommunist Party ...
Rosa DeLauro’s Marriage: More Than Just Love?
Congresswoman Rosa DeLauro, of Connecticut’s 3rd District, and her husband may be engaging in more than just marriage. According to Human Events, federal campaign records show that, during the last four congressional election cycles, Congresswoman DeLauro’s campaign transferred $1.2 million to the Democratic Congressional Campaign Committee (DCCC), the branch of the House Democrats that deals with fundraising and recruitment. During that same period of time, the DCCC engaged Stanley Greenberg, Ms. DeLauro’s husband, and his firm, for polling and other services pertinent to ...
|
DeLauro Statement on Health and Human Services Budget Hearing WASHINGTON, DC (February 25, 2016) — Congresswoman Rosa DeLauro (CT-03) today delivered the following statement at an Appropriations subcommittee hearing on the budget for the Department of Health and Human Services. DeLauro is the senior Democrat on the subcommittee responsible for funding the departments of Labor, Health and Human Services, and Education. Here are the remarks, as prepared for delivery: Thank you, Mr. Chairman. Madam Secretary, welcome back to the Labor-HHS subcommittee. It has been exactly one year to the day since your last appearance here. I want to express my gratitude for the work you and your Department do. First let me start by thanking Chairman Cole. Together, we were able to make many great investments in the Labor Health and Human Services bill last year. In many ways, last year’s Omnibus moved the federal budget in the right direction. It began to leave behind the shortsighted policies of austerity that have slowe |
House Democrats Urge Administration to Take Immediate Action to Stop Corporate Inversions WASHINGTON, DC (February 25, 2016) — Today, several Democratic Members of Congress, along with the Executive Director of Americans for Tax Fairness, Frank Clemente, released a major new report on the extent of Pfizer’s tax dodging and price gouging, as well as a letter to Treasury Secretary Jack Lew urging the Administration to use its executive authority to deny the tax benefits of the proposed corporate inversion. Seven senators, led by Assistant Majority Leader Richard Durbin, sent a similar letter to Secretary Lew today as well. Pfizer – maker of Celebrex, Lipitor, Lyrica, and Viagra – is attempting to permanently dodge an estimated $35 billion of U.S. taxes it currently owes by merging with Allergan, a drug firm based in Ireland, according to a new Americans for Tax Fairness report that was released today. The report also documents a rapid rise in Pfizer’s prescription drug prices in recent years, and it compares the vast di |
DeLauro Statement on the Task Force on Poverty, Opportunity, and Upward Mobility WASHINGTON, DC (February 24, 2016) — Congresswoman Rosa DeLauro (CT-03) today released the following statement regarding Speaker Ryan’s newly formed Task Force on Poverty, Opportunity, and Upward Mobility. “Speaker Ryan and his Republican colleagues want to address poverty and opportunity, yet they do not include a single Democrat on their new task force. Creating a task force that will not result in a meaningful discussion is an injustice to the millions of Americans living in poverty. The American people need leadership, not showmanship, and without a bipartisan effort, we cannot pass legislation that will move our country forward. If Speaker Ryan and his colleagues want to address poverty, they need to reach across the aisle. I will be the first to join.” ### |
DeLauro Statement on FDA’s Review of Essure WASHINGTON, DC (February 29, 2016) —Congresswoman Rosa DeLauro (CT-03) today released the following statement regarding the U.S. Food and Drug Administration’s new measures to evaluate the risk of Essure, a permanent form of contraception. DeLauro secured language in the FY 2016 Omnibus bill requiring FDA to complete a review of the device by the end of February. “Women and their doctors have filed more than 5,000 adverse events reports to the FDA regarding the negative side effects of Essure, yet the device is still on the market. While conducting a postmarket study and issuing labeling recommendations are positive developments, these actions mean nothing unless the FDA is able to take action. “Last year, the its findings on a report I commissioned, showing that the FDA’s requests for postmarket safety studies often take a long time to be completed, and that companies lack incentive to find participants for their studies. Now, the |
> Rosa DeLauro > Supporters |
[TOP 1] |
|